Literature DB >> 23329182

Cardiovascular risk in Japanese-Brazilian subjects.

Patricia Moreira Gomes1, Regina Célia Garcia de Andrade, Roberta Carvalho de Figueiredo, Ana Emília Pace, Amaury Lelis Dal Fabbro, Laércio Joel Franco, Milton César Foss, Maria Cristina Foss-Freitas.   

Abstract

OBJECTIVE: To evaluate the prevalence of risk factors for cardiovascular disease in Japanese-Brazilian subjects. SUBJECTS AND METHODS: One hundred thirty-one residents of the Mombuca community were studied. Statistical analysis was based on the X² test, Fisher's Exact test, Student's t test, and ANOVA, at a 5% significance level.
RESULTS: The average age was 56.7 years-old; 76.3% had dyslipidemia, 24.4% pre-diabetes (PDM), 10.7% type 2 diabetes mellitus (T2DM), 46.6% hypertension, 52.7% abdominal obesity, and 35.8% metabolic syndrome (MS). There were significant correlations between HOMA-IR and MS diagnosis and obesity, while HOMA-β levels were decreased in T2DM and PDM. The ankle-brachial index was positive for peripheral artery disease in 22.3% of the individuals. Electrocardiograms did not show increased evidence of myocardial ischemia.
CONCLUSION: Subjects of this community are exposed to major cardiovascular risk factors, namely high prevalence of MS diagnoses and increased HOMA-IR.

Entities:  

Mesh:

Year:  2012        PMID: 23329182     DOI: 10.1590/s0004-27302012000900002

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  2 in total

1.  Risk Factors Associated with Overweight and Obesity in Japanese-Brazilians.

Authors:  Ivi R Back; Rosana R Oliveira; Eraldo S Silva; Sonia S Marcon
Journal:  J Nutr Metab       Date:  2018-05-08

2.  Prevalence of metabolic syndrome in Brazilian adults in the last 10 years: a systematic review and meta-analysis.

Authors:  Letícia Teixeira de Siqueira Valadares; Luiza Siqueira Barreto de Souza; Valdir Alves Salgado Júnior; Larissa de Freitas Bonomo; Leandro Roberto de Macedo; Maísa Silva
Journal:  BMC Public Health       Date:  2022-02-16       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.